CNS & Neurological Disorders-Drug Targets

Papers
(The H4-Index of CNS & Neurological Disorders-Drug Targets is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Meet the Editorial Board Member89
Meet the Regional Editor78
Neurobiology of Amphetamine use in Stroke Recovery Combined with Rehabilitative Training and Brain Stimulation55
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus55
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single 51
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment48
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives46
The Potential Effect of Blueberry on Cognitive Health and Mood State based on Human Intervention Studies: Systematic Review and Mini Meta-Analysis42
Restless Leg Syndrome in Patients with Liver Cirrhosis! Its Frequency, Severity, and Correlation35
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis33
Recent Trends in Physical Therapy Interventions and Neuromodulation Techniques to Improve Neurorehabilitation33
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease29
Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-Induced Allodynia and Hyperalgesia in a 28
Targeting JNK3: An In-silico Approach to Uncover Potential Therapeutics for Alzheimer's Disease26
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders26
Cholinesterase Inhibitory and In Silico Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound25
Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson’s Disease: Exploring Nanoparticle-based Gene Therapies25
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease24
Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia23
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review23
GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature22
Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis21
Insights into the Diagnosis, Treatment, and Management of Prion Diseases21
Unraveling the Triad: A Bioinformatics Analysis of the Interplay between Prenatal Depression, Inflammation, and the Gut Microbiota21
Pathological Insights into Neurodegenerative and Neurodevelopmental Disorders: Perspectives for the Development of Novel Treatment Approaches21
0.1194851398468